Skip to main content
Signal8

CollPlant Biotechnologies Ltd (CLGN) Form 6-K — Nov 2, 2026

$CLGNForm 6-KFiled Nov 2, 2026, 4:30 PM ET0001213900-26-114972Original filing

CollPlant Biotechnologies announced that CEO Yehiel Tal will cease serving as CEO effective immediately, a determination made by the Board on November 2, 2026 in connection with a broader cost-reduction plan. Tal also resigned as Interim Chairman but will remain on the Board. The Board appointed Eran Rotem, previously Deputy CEO and CFO, as Chief Executive Officer. Rotem will continue to serve as CFO with his compensation terms unchanged.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.